Clinical Trials Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial 05 Mar 2021
Tetra starts Phase ll Trial of BPN14770 for Fragile X Syndrome Tetra Discovery Partners has commenced a Phase ll trial of BPN14770 for the treatment of... 11th July 2018
Clinical Trials Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial 05 Mar 2021
Clinical Trials Dicerna and Roche start Phase II trial of GalXC RNAi candidate in hepatitis B 05 Mar 2021
Clinical Trials Marker Therapeutics treats first subject in acute myeloid leukaemia trial 04 Mar 2021